<!DOCTYPE html> <html class="aui ltr HUWC-UFC---Hospital-Universitário-Walter-Cantídio" dir="ltr" lang="pt-BR">
<!-- Mirrored from www.ebserh.gov.br/web/huwc-ufc/pesquisa by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 05 Mar 2018 05:20:26 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=UTF-8" /><!-- /Added by HTTrack -->
<head>
	<title>Pesquisa - EBSERH</title> <script type="text/javascript" src="../../ebserh-internet-theme/js/jquery-1.11.0.min.js"></script> <script type="text/javascript" src="../../ebserh-internet-theme/js/jquery.cookie.js"></script> <script type="text/javascript" src="../../ebserh-internet-theme/js/bootstrap-collapse.js"></script> <script type="text/javascript" src="../../ebserh-internet-theme/js/bootstrap-transition.js"></script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://www.ebserh.gov.br/ebserh-internet-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="pesquisa.html" rel="canonical" /> <link class="lfr-css-file" href="../../ebserh-internet-theme/css/aui5183.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1473776398000" rel="stylesheet" type="text/css" /> <link href="../../html/css/main74cf.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1383318338000" rel="stylesheet" type="text/css" /> <link href="../../html/portlet/asset_publisher/css/main8801.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652254000" rel="stylesheet" type="text/css" /> <link href="../../notifications-portlet/notifications/css/maind0ad.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652236000" rel="stylesheet" type="text/css" /> <link href="../../acesso-hospitais-portlet/css/mainecf6.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652255000" rel="stylesheet" type="text/css" /> <link href="../../acesso-hospitais-portlet/css/chosenecf6.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652255000" rel="stylesheet" type="text/css" /> <link href="../../html/portlet/search/css/main8801.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652254000" rel="stylesheet" type="text/css" /> <link href="../../html/portlet/journal/css/main8801.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652254000" rel="stylesheet" type="text/css" /> <link href="../../html/portlet/login/css/main8801.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652254000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return true},getMajorVersion:function(){return 0},getRevision:function(){return""},getVersion:function(){return""},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return false},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return false},isSafari:function(){return false},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return false},isWindows:function(){return true},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"45"},getLayoutURL:function(){return"http://www.ebserh.gov.br/web/huwc-ufc/pesquisa"},getParentLayoutId:function(){return"8"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"pt-BR"},getCDNBaseURL:function(){return"http://www.ebserh.gov.br"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"10157"},getCompanyGroupId:function(){return"10197"},getDefaultLanguageId:function(){return"pt_BR"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"pt_BR"},getParentGroupId:function(){return"214604"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/c"},getPathThemeImages:function(){return"http://www.ebserh.gov.br/ebserh-internet-theme/images"},getPathThemeRoot:function(){return"/ebserh-internet-theme"},getPlid:function(){return"804576"},getPortalURL:function(){return"http://www.ebserh.gov.br"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"214604"},getScopeGroupIdOrLiveGroupId:function(){return"214604"},getSessionId:function(){return""},getSiteGroupId:function(){return"214604"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=804576"},getURLHome:function(){return"http\x3a\x2f\x2fwww\x2eebserh\x2egov\x2ebr\x2fweb\x2fportal-ebserh\x2finicio"},getUserId:function(){return"10161"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=ebserhinternet_WAR_ebserhinternettheme&colorSchemeId=01&minifierType=js&languageId=pt_BR&b=6210&t=1427304579000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=pt_BR&b=6210&t=1427304579000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=ebserhinternet_WAR_ebserhinternettheme&colorSchemeId=01&minifierType=js&languageId=pt_BR&b=6210&t=1427304579000"}};Liferay.authToken="HgAjlPHU";Liferay.currentURL="\x2fweb\x2fhuwc-ufc\x2fpesquisa";Liferay.currentURLEncoded="%2Fweb%2Fhuwc-ufc%2Fpesquisa";</script> <script src="http://www.ebserh.gov.br/html/js/barebone.jsp?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=pt_BR&amp;b=6210&amp;t=1427304579000" type="text/javascript"></script> <script type="text/javascript">Liferay.Portlet.list=["71_INSTANCE_dm2zxVz2POIF","101_INSTANCE_jJ5D5VaFLatP","acessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7","3_INSTANCE_Busc4","85_INSTANCE_assuntos1","15","58","3","101"];</script> <script src="../../acesso-hospitais-portlet/js/chosen.jquery8e96.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652255000" type="text/javascript"></script> <script src="../../html/portlet/journal/js/main742c.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652254000" type="text/javascript"></script> <script src="../../html/portlet/journal/js/navigation742c.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652254000" type="text/javascript"></script> <link class="lfr-css-file" href="../../ebserh-internet-theme/css/main5183.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1473776398000" rel="stylesheet" type="text/css" /> <style type="text/css">.portlet-close{display:none!important}</style> <style type="text/css">#p_p_id_71_INSTANCE_dm2zxVz2POIF_ .portlet-borderless-container{border-width:;border-style:}</style> <link rel="stylesheet" type="text/css" href="http://fonts.googleapis.com/css?family=Open+Sans"> <!--[if gte IE 9]> <style type="text/css">.gradient{filter:none}</style> <![endif]--> </head> <body class="default yui3-skin-sam controls-visible signed-out public-page site"> <div id="wrapper"> <!-- A barra Brasil e atualizada remotamente e não deve ser alterada ou removida da template --> <div id="barra-brasil" style="background:#7F7F7F; height: 20px; padding:0 0 0 10px;display:block;"> <ul id="menu-barra-temp" style="list-style:none;"> <li style="display:inline; float:left;padding-right:10px; margin-right:10px; border-right:1px solid #EDEDED"><a href="http://brasil.gov.br/" style="font-family:sans,sans-serif; text-decoration:none; color:white;">Portal do Governo Brasileiro</a></li> <li><a style="font-family:sans,sans-serif; text-decoration:none; color:white;" href="http://epwg.governoeletronico.gov.br/barra/atualize.html">Atualize sua Barra de Governo</a></li> </ul> </div> <header id="banner" role="banner"> <div class="container"> <a id="back-top"></a> <ul id="acessibility" class="fixospan5">
		<li><a accesskey="1" href="#column-2" id="link-conteudo"> Ir para o conteúdo <span>1</span> </a></li> <li><a accesskey="2" href="#column-1" id="link-navegacao"> Ir para o menu <span>2</span> </a></li> <li><a accesskey="3" href="#irparaorodape" id="link-rodape"> Ir para o rodapé <span>3</span> </a></li> </ul> <ul id="portal-siteactions" class="fixospan4 pull-right offset"> <li id="siteactions-altocontraste"><a href="#" id="alto_contraste_id" class="contraste_off" title="Alto Contraste" accesskey="6">Alto Contraste</a></li> <li> <a class="cadeado" data-redirect="false" href="http://www.ebserh.gov.br/c/portal/login?p_l_id=804576" rel="nofollow" data-toggle="tooltip" title="Entrar"><span class="icon-lock"></span></a> </li> </ul> <div id="heading" class="fixospan3"> <h1 class="site-title"> <a class="logo custom-logo fixospan3" href="http://www.ebserh.gov.br/" title="HUWC-UFC - Hospital Universitário Walter Cantídio"> <img alt="HUWC-UFC - Hospital Universitário Walter Cantídio" height="60" src="http://www.ebserh.gov.br/image/layout_set_logo?img_id=214609&amp;t=1520226456613" width="177" /> <div class="site-main-title"> <span class="site-name" title="Go to HUWC-UFC - Hospital Universitário Walter Cantídio"> HUWC-UFC - Hospital Universitário Walter Cantídio </span> </div> </a> </h1> </div> <div class="fixospan3 acesso-aos-hospitais"> <div class="portlet-boundary portlet-boundary_acessohospitais_WAR_acessohospitaisportlet_ portlet-static portlet-static-end acesso-hospitais-portlet " id="p_p_id_acessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7_" > <span id="p_acessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7"></span> <section class="portlet" id="portlet_acessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Acesso\x20Hospitais')" > <img id="owel_null_null" src="../../acesso-hospitais-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Acesso Hospitais</span> </span> <span class="portlet-title-text">Acesso Hospitais</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_acessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container" style=""> <div class="portlet-body"> <select name="hospitais" id="acesso-rapido-hospitais" data-placeholder="Acesso aos Hospitais Universitários"> <option value=""></option> <option value="/web/chc-ufpr">CHC-UFPR - Complexo Hospital de Clínicas da UFPR</option> <option value="/web/hc-ufg">HC-UFG - Hospital das Clínicas de Goiás</option> <option value="/web/hc-ufmg">HC-UFMG - Hospital das Clínicas da Universidade Federal de Minas Gerais</option> <option value="/web/hc-ufpe">HC-UFPE - Hospital das Clínicas da Universidade Federal de Pernambuco</option> <option value="/web/hc-uftm">HC-UFTM - Universidade Federal do Triângulo Mineiro</option> <option value="/web/hdt-uft">HDT-UFT - Hospital de Doenças Tropicais - Universidade Federal do Tocantins</option> <option value="/web/hu-furg">HU-FURG - Hospital Universitário Dr. Miguel Riet Corrêa Jr</option> <option value="/web/hu-ufgd">HU-UFGD - Hospital Universitário da Universidade Federal da Grande Dourados</option> <option value="/web/hu-ufjf">HU-UFJF - Hospital Universitário da Universidade Federal de Juiz de Fora</option> <option value="/web/hu-ufma">HU-UFMA - Hospital Universitário da Universidade Federal do Maranhão</option> <option value="/web/hu-ufpi">HU-UFPI - Hospital Universitário da Universidade Federal do Piauí</option> <option value="/web/hu-ufs">HU-UFS - Hospital Universitário da Universidade Federal de Sergipe</option> <option value="/web/hu-ufscar">HU-UFSCar - Hospital Universitário da UFSCar</option> <option value="/web/hu-univasf">HU-UNIVASF - Hospital de Ensino da Universidade Federal do Vale do São Francisco</option> <option value="/web/huab-ufrn">HUAB-UFRN - Hospital Universitário Ana Bezerra da Universidade Federal do Rio Grande do Norte</option> <option value="/web/huac-ufcg">HUAC-UFCG - Hospital Universitário Alcides Carneiro</option> <option value="/web/huap-uff">HUAP-UFF - Hospital Universitário Antônio Pedro - Universidade Federal Fluminense</option> <option value="/web/hub-unb">HUB-UnB - Hospital Universitário de Brasília da Universidade de Brasília</option> <option value="/web/hucam-ufes">HUCAM-UFES - Hospital Universitário Cassiano Antonio Moraes da Universidade Federal do Espírito Santo</option> <option value="/web/hugg-unirio">HUGG-Unirio - Hospital Universitário Gafrée e Guinle</option> <option value="/web/hujb-ufcg">HUJB-UFCG - Hospital Universitário Júlio Bandeira</option> <option value="/web/hujm-ufmt">HUJM-UFMT - Hospital Universitário Julio Muller da Universidade Federal do Mato Grosso</option> <option value="/web/hulw-ufpb">HULW-UFPB - Hospital Universitário Lauro Wanderley</option> <option value="/web/humap-ufms">HUMAP-UFMS - Hospital Universitário Maria Aparecida Pedrossian da Universidade Federal de Mato Grosso do Sul</option> <option value="/web/huol-ufrn">HUOL-UFRN - Hospital Universitário Onofre Lopes da Universidade Federal do Rio Grande do Norte</option> <option value="/web/hupaa-ufal">HUPAA-UFAL - Hospital Universitário Professor Alberto Antunes da Universidade Federal de Alagoas</option> <option value="/web/hupes-ufba">HUPES-UFBA - Complexo Hospitalar Universitário Professor Edgard Santos</option> <option value="/web/husm-ufsm">HUSM-UFSM- Hospital Universitário de Santa Maria</option> <option value="/web/huwc-ufc">HUWC-UFC - Hospital Universitário Walter Cantídio</option> <option value="/web/mco-ufba">MCO-UFBA - Maternidade Climério de Oliveira</option> <option value="/web/meac-ufc">MEAC-UFC - Maternidade Escola Assis Chateaubriand da Universidade Federal do Ceará</option> <option value="/web/mejc-ufrn">MEJC-UFRN - Maternidade Escola Januário Cicco da UFRN</option> </select> </div> </div> </div> </section> </div> </div> <a id="irparaabusca"></a> <div id="portal-searchbox" class="fixospan3 p-searchbox"> <link href="../../ebserh-busca-avancada-portlet/css/main716e.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" rel="stylesheet" type="text/css" /> <link href="../../ebserh-busca-avancada-portlet/css/jquery.dataTables716e.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" rel="stylesheet" type="text/css" /> <link href="../../ebserh-busca-avancada-portlet/css/jquery-ui716e.css?browserId=other&amp;themeId=ebserhinternet_WAR_ebserhinternettheme&amp;minifierType=css&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" rel="stylesheet" type="text/css" /> <div class="portlet-boundary portlet-boundary_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_ portlet-static portlet-static-end ebserh-busca-avancada-portlet " id="p_p_id_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_" > <span id="p_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7"></span> <section class="portlet" id="portlet_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Ebserh\x20Busca\x20Avancada')" > <img id="bvrs_null_null" src="../../ebserh-busca-avancada-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Ebserh Busca Avancada</span> </span> <span class="portlet-title-text">Ebserh Busca Avancada</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container" style=""> <div class="portlet-body"> <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> <!-- <form id="pesquisar-noticias" method="POST" class="form" > --> <div class="row-fluid portlet-busca-avancada"> <div class="span12"> <fieldset> <div class="form-group"> <div class="boxGet busca"> <!-- <span class="help-block"></span> --> <input class="form-control input-md termosBusca" id="_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca" name="_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca" type="text"
					 value="" placeholder="Buscar por..."/> <input align="absmiddle" border="0" src="../../ebserh-internet-theme/images/common/search.png" title="Pesquisar" type="image" id="_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_lupa" style="width: 21px; margin-top: -10px; margin-left: -28px;"  /> </div> </div> </fieldset> </div> <div class="clearfix"></div> <script>var _ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar="pesquisa8104.html?p_auth=HgAjlPHU&amp;p_p_id=ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_javax.portlet.action=pesquisarAssets";var pesquisarAssetsURL="pesquisa8104.html?p_auth=HgAjlPHU&amp;p_p_id=ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_javax.portlet.action=pesquisarAssets";var caminhoListaResultado="null";var _ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance="ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7";var _ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath;var _ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_groupUrl;var _ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca="";_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath="/30";_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_groupUrl="../huwc-ufc.html";if(!(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath.indexOf(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_groupUrl)!=-1)){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath="/web/huwc-ufc/30"}var popupURL="pesquisa32cf.html?p_p_id=ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7&amp;p_p_lifecycle=0&amp;p_p_state=pop_up&amp;p_p_mode=view";var paginaBuscaUrl="null.html";portletName="ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7";var windowPreferences;instanceId="E3j7";popupURL=popupURL.replace("mode=view","mode=edit");var executouUmaVez=false;var countExec=1;$(document.getElementsByTagName("a")).each(function(){if($(this).attr("id")!=undefined){if($(this).attr("id").indexOf("menu_preferences")!=-1){$(this).attr("href","javascript:openPreferencesPopup(this)")}}});$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").keydown(function(event){var keypressed=event.keyCode||event.which;if(keypressed==13){if(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath.indexOf("null")!=-1){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath.replace("null","/resultado-busca")}count=0;variables2=Object.keys(window);var x;for(count;count<variables2.length;count++){x=variables2[count];if(x.indexOf("actionPesquisar")!=-1){if(!(x.indexOf("ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7")!=-1)){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar=eval(x)}}}countResult=0;variables2=Object.keys(window);var x;for(countResult;countResult<variables2.length;countResult++){x=variables2[countResult];if(x.indexOf("resultadoPath")!=-1){if(!(x.indexOf("ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7")!=-1)){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=eval(x)}}}if(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=="null"){countVar=0;variables=Object.keys(window);var x;for(countVar;countVar<variables.length;countVar++){x=variables[countVar];if(x.indexOf("resultadoPath")!=-1){if(eval(x)!="null"){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=eval(x)}}}}var a=document.createElement("a");if(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath!=null){a.href=document.location.protocol+"//"+document.location.host+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath+"?"+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar.split("?")[1]+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val()+"&pesquisaPadrao=true&tipoPesquisa=noticias&instance="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&resultado="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath+"&action=true"}else{a.href=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val()+"&pesquisaPadrao=true&tipoPesquisa=noticias&instance="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&resultado="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath+"&action=true"}a.target="_self";document.body.appendChild(a);a.click();executouUmaVez=true;countExec++}else{countExec=1}});function openPreferencesPopup(b){windowPreferences=Liferay.Util.openWindow({dialog:{title:"Preferências De Busca Avançada",cache:false,width:1200,height:700,modal:true},exibirPreferencias:"true",uri:popupURL+"&exibirPreferencias=true"});b.href=windowPreferences;$(".modal-header button").each(function(){$(this).attr("onclick","recarregarView()")})}function recarregarView(){document.location.href=document.location.protocol+"//"+document.location.host+document.location.pathname+"?p_p_id="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&p_p_state=normal&p_p_mode=view"}function submeterPesquisa(d,c){var b=document.createElement("a");if($(d).val()=="noticias"){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar.replace("&tipoPesquisa=demaisConteudos","");_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar.replace("&tipoPesquisa=noticias","");b.href=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val()+"&pesquisaPadrao=true&tipoPesquisa=noticias&instance="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&resultado="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath}else{if($(d).val()=="demaisConteudos"){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar.replace("&tipoPesquisa=noticias","");_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar.replace("&tipoPesquisa=demaisConteudos","");b.href=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val()+"&pesquisaPadrao=true&tipoPesquisa=demaisConteudos&instance="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&resultado="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath}else{b.href=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val()+"&pesquisaPadrao=true&tipoPesquisa=demaisConteudos&instance="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&resultado="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath}}b.target="_self";document.body.appendChild(b);b.click()}$(document).on("ready",function(){$(".highlight").css({backgroundColor:"#FFFF00"});$(".displayResult").highlight($("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val(),{backgroundColor:"#FFFF00"});$(".highlight").css({backgroundColor:"#FFFF00"});var termoBuscaPesquisa="";$(".termosBusca").each(function(){if($(this).val()!=""){termoBuscaPesquisa=$(this).val()}});$(".termosBusca").each(function(){if($(this).val()==""){$(this).val(termoBuscaPesquisa)}});$(".displayResult a").each(function(){if($(this).attr("href").indexOf("/inicio")){$(this).attr("href",$(this).attr("href").replace("/inicio",""))}});$(".pager a").click(function(){$(this).attr("href",$(this).attr("href")+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val())});count=0;variables2=Object.keys(window);var x;for(count;count<variables2.length;count++){x=variables2[count];if(x.indexOf("termosBusca")!=-1){if((x.indexOf("")!=-1)){$(".busca input").each(function(){if($(this).attr("type")=="text"){$(this).val(eval(x))}})}}}});$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_lupa").click(function(){count=0;variables2=Object.keys(window);var x;for(count;count<variables2.length;count++){x=variables2[count];if(x.indexOf("actionPesquisar")!=-1){if(!(x.indexOf("ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7")!=-1)){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar=eval(x)}}}if(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath.indexOf("null")!=-1){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath.replace("null","/resultado-busca")}if(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=="null"){countVar=0;variables=Object.keys(window);var x;for(countVar;countVar<variables.length;countVar++){x=variables[countVar];if(x.indexOf("resultadoPath")!=-1){if(eval(x)!="null"){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=eval(x)}}}}countResult=0;variables2=Object.keys(window);var x;for(countResult;countResult<variables2.length;countResult++){x=variables2[countResult];if(x.indexOf("resultadoPath")!=-1){if(!(x.indexOf("ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7")!=-1)){_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath=eval(x)}}}var a=document.createElement("a");if(_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath!=null){a.href=document.location.protocol+"//"+document.location.host+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath+"?"+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar.split("?")[1]+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val()+"&pesquisaPadrao=true&tipoPesquisa=noticias&instance="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&resultado="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath+"&action=true"}else{a.href=_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_actionPesquisar+"&termosBusca="+$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_termosBusca").val()+"&pesquisaPadrao=true&tipoPesquisa=noticias&instance="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_instance+"&resultado="+_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_resultadoPath+"&action=true"}a.target="_self";document.body.appendChild(a);a.click();executouUmaVez=true});$("#_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_lupa").css("margin-top","0px");</script> <div class="result displayResult" id="result"> </div> </div> </div> </div> </div> </section> </div> <script src="../../ebserh-busca-avancada-portlet/js/jquery.maskedinput1f09.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" type="text/javascript"></script> <script src="../../ebserh-busca-avancada-portlet/js/main1f09.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" type="text/javascript"></script> <script src="../../ebserh-busca-avancada-portlet/js/jquery.dataTables1f09.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" type="text/javascript"></script> <script src="../../ebserh-busca-avancada-portlet/js/jquery-ui1f09.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" type="text/javascript"></script> <script src="../../ebserh-busca-avancada-portlet/js/jquery.highlight1f09.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" type="text/javascript"></script> <script src="../../ebserh-busca-avancada-portlet/js/jspdf.debug1f09.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" type="text/javascript"></script> <script src="../../ebserh-busca-avancada-portlet/js/bootstrap/bootstrap.min1f09.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652264000" type="text/javascript"></script> </div> <aside id="social-media" class=""> <a href="https://www.youtube.com/channel/UCsvsX24Q6g-kckH93PL1FGw" class="icon-boxyoutube" alt="YouTube" title="YouTube" target="_blank"><span>YouTube</span></a> <a href="https://www.flickr.com/photos/complexohospitalardaufc/albums/with/72157684893816272" class="icon-boxflickr" alt="Flickr" title="Flickr" target="_blank"><span>Flickr</span></a> </aside> </div> </header> <div id="header-bar"> <div class="container"> <ul class="servicos pull-right"> </ul>
					 </div> </div> <div id="content"> <div class="container"> <div class="topo-hu row-fluid gradient estilo-azul-azul"> <div class="logotipo-hu span5"> <a href="inicio.html" > <img alt="Logotipo do HU" src="http://www.ebserh.gov.br/documents/214604/1381173/Novo+topo+HUWC+2.1/57338285-24ae-4af8-bfc1-478cb88be978?t=1470925202766" /> </a> </div> <div class="span7 com-imagem"> <p class="hu"> <span class="nome-hu">Hospital Universitário Walter Cantídio</span> </p> <p class="universidade"> <span class="nome-universidade">Universidade Federal do Ceará</span> </p> </div> </div> <nav id="breadcrumbs" class=""> <ul aria-label="Breadcrumb" class="breadcrumb breadcrumb-horizontal"> <li class="first breadcrumb-truncate"><a href="../portal-ebserh.html">Portal Ebserh</a><span class="divider">/</span></li><li><a href="../huwc-ufc.html">HUWC-UFC - Hospital Universitário Walter Cantídio</a><span class="divider">/</span></li><li><a href="assuntos.html" >Assuntos</a><span class="divider">/</span></li><li class="current-parent breadcrumb-truncate"><a href="ensino-e-pesquisa.html" >Ensino e Pesquisa</a><span class="divider">/</span></li><li class="active last breadcrumb-truncate"><a href="pesquisa.html" >Pesquisa</a><span class="divider">/</span></li> </ul> </nav> <div id="barra-destaques"> <div class="etiqueta-destaques item"> <span>Em Destaque:</span> </div> <div class="item"> <a href="http://sig.ebserh.gov.br/vigihosp/index.php?hosp=HUWCUFC" title="Vigihosp">Vigihosp</a> </div> </div> <div class="ebserh_2_colunas_secom" id="main-content" role="main"> <div class="portlet-layout row-fluid"> <div class="aui-w15 span2 portlet-column coluna-menu-lateral portlet-column-first" id="column-1"> <div class="portlet-dropzone portlet-column-content portlet-column-content-first" id="layout-column_column-1"> <div class="portlet-boundary portlet-boundary_71_ portlet-static portlet-static-end portlet-borderless portlet-navigation " id="p_p_id_71_INSTANCE_dm2zxVz2POIF_" > <span id="p_71_INSTANCE_dm2zxVz2POIF"></span> <div class="portlet-borderless-container" style=""> <div class="portlet-body"> <div class="nav-menu nav-menu-style-dots"> <ul class="layouts level-1"><li class="open " ><a class="open " href="inicio.html" > Página Inicial</a><ul class="layouts level-2"><li class="open " ><a class="open " href="http://www.ebserh.gov.br/we/huwc-ufc/noticias" > Notícias</a></li></ul></li><li class="open " ><a class="open " href="ensino-e-pesquisa.html" > Ensino e Pesquisa</a>
					  	<ul class="layouts level-2"><li class="open " ><a class="open " href="ensino.html" > Ensino</a></li><li class="open selected" ><a class="open selected" href="pesquisa.html" > Pesquisa</a></li></ul></li><li class="open " ><a class="open "> Sites Externos</a><ul class="layouts level-2"><li class="open " ><a class="open " href="http://www.ebserh.gov.br/web/huwc-ufc/" > HUWC</a></li><li class="open " ><a class="open " href="http://www.ebserh.gov.br/web/meac-ufc/" > MEAC</a></li></ul></li></ul> </div> </div> </div> </div> </div> </div> <div class="aui-w85 span10 portlet-column coluna-conteudo-principal portlet-column-last" id="column-2"> <div class="portlet-dropzone portlet-column-content portlet-column-content-last" id="layout-column_column-2"> <div class="portlet-boundary portlet-boundary_101_ portlet-static portlet-static-end portlet-asset-publisher " id="p_p_id_101_INSTANCE_jJ5D5VaFLatP_" > <span id="p_101_INSTANCE_jJ5D5VaFLatP"></span> <section class="portlet" id="portlet_101_INSTANCE_jJ5D5VaFLatP"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Ensino\x20e\x20Pesquisa')" > <img id="rjus_column2_0" src="../../ebserh-internet-theme/images/spacer.png" alt="" style="background-image: url('../../sprite/html/icons/_sprite.png'); background-position: 50% -112px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Ensino e Pesquisa</span> </span> <span class="portlet-title-text">Ensino e Pesquisa</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_101_INSTANCE_jJ5D5VaFLatP" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container" style=""> <div class="portlet-body">



					 		<div class="portlet-column portlet-column-last span8" id="_101_INSTANCE_jJ5D5VaFLatP_814517_columns-1">



					 		<div class="lfr-meta-actions add-asset-selector">
					 		</div> <div class="subscribe-action"> </div> <div class="asset-full-content no-title"> <div class="asset-content" id="_101_INSTANCE_jJ5D5VaFLatP_814517"> <div class="journal-content-article"> <div class="taglib-header "> <h3 class="header-title"> <span></span> </h3> </div> <div class="asset-full-content show-asset-title"> <div class="asset-content" id="_101_INSTANCE_jJ5D5VaFLatP_811263"> <div class="journal-content-article"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Pesquisas\x20em\x20Andamento')" > <img id="rjus_column2_0" src="../../ebserh-internet-theme/images/spacer.png" alt="" style="background-image: url('../../sprite/html/icons/_sprite.png'); background-position: 50% -112px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Pesquisas em Andamento</span></span> <span class="portlet-title-text">Pesquisas em Andamento</span> </h1></header>
													<menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_85_INSTANCE_9nyeGdwgU4qN" type="toolbar"> </menu></div></div></div> <div class="accordion" id="accordion"> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse1">Cardiologia</a> </div> <div id="collapse1" class="accordion-body collapse"> <div class="accordion-inner"> <p style="margin-top:0cm;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm"><strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">&nbsp;</span>
													</span><span style="font-size:10.5pt;font-family: &quot;Helvetica&quot;,sans-serif;color:#555555">Estudo randomizado, duplo-cego, controlado por placebo, de grupos paralelos para avaliar o efeito do SAR236553/REGN727 na ocorrência de eventos cardiovasculares em pacientes que apresentaram uma síndrome coronariana aguda recentemente (Odyssey)<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size: 10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:firebrick">Recrutamento completo</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com síndrome coronariana aguda<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Ricardo Pereira da Silva<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">---------------------------------------------------------------------------------<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:&nbsp;</span></strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Estudo Fase 3, Multicêntrico, duplo-cego, randomizado, controlado por placebo, de grupos paralelos para avaliar a eficácia, segurança e tolerabilidade do BUCOCIZUMABE (PF-04950615)<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size: 10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:firebrick">Recrutamento completo</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com alto risco de ocorrência de eventos cardiovasculares<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Ricardo Pereira da Silva<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">---------------------------------------------------------------------------------<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:&nbsp;</span></strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Estudo randomizado, duplo-cego, controlado por placebo, orientado por eventos, da administração subcutânea trimestral de canaquinumabe na prevenção de eventos cardiovasculares reorrentes em pacientes estáveis pos infarto do miocárdio com PCRus elevada – CANTOS.<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size: 10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:firebrick">Recrutamento completo</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes que tiveram infarto do miocárdio com PCRus elevada<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Ricardo Pereira da Silva<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> </div> </div> </div> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse2">Endocrinologia</a> </div> <div id="collapse2" class="accordion-body collapse"> <div class="accordion-inner"> <p style="margin-top:0cm;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm"><strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt; font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Estudo clínico multicêntrico, internacional, randomizado, de grupos paralelos, duplo-cego, controlado por placebo sobre a segurança cardiovascular e sobre o resultado microvascular renal com a linagliptina a 5 mg uma vez ao dia em pacientes com diabete melito&nbsp;do tipo 2 com risco vascular elevado (CARMELINA)<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size: 10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:firebrick">Recrutamento completo</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com DM tipo 2 com risco vascular elevado<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Renan Magalhães Montenegro Júnior<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">---------------------------------------------------------------------------------<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:&nbsp;</span></strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Estudo multicêntrico, randomizado, duplo-cego, orientado por eventos, controlado por placebo, dos efeitos da canagliflozina nos resultados renais e cardiovasculares em participantes com diabetes mellitus tipo 2 e nefropatia diabética (CREDENCE).<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size: 10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:firebrick">Recrutamento completo</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com DM tipo 2 e nefropatia diabética<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Renan Magalhães Montenegro Júnior<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">---------------------------------------------------------------------------------<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:&nbsp;</span></strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Estudo clínico internacional, multicêntrico, randomizado, duplo-cego, controlado por placebo e de fase 3 que investiga a eficácia e a segurança de rivaroxabana para redução do risco de eventos vasculares trombóticos importantes em pacientes que apresentam arteriopatia periférica sintomática submetidos a procedimentos de revascularização de extremidades inferiores (VOYAGER).<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="color:#008000;"><span style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size: 10.5pt; font-family: Helvetica, sans-serif;">Recrutamento aberto</span></span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com arteriopatia periférica que realizaram procedimentos de revascularização.<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Renan Magalhães Montenegro Júnior&nbsp;<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">---------------------------------------------------------------------------------<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:&nbsp;</span></strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Estudo de Fase 3, Multicêntrico, Randomizado, Duplo-Cego, Controlado por Placebo que Avalia a Segurança e a Eficácia de Roxadustat para o Tratamento de Anemia em Participantes da pesquisa com Doença Renal Crônica que Não Recebem Diálise (OLYMPUS)<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size: 10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:firebrick">Recrutamento completo</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com anemia e doença renal crônica que não realizam diálise<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Renan Magalhães Montenegro Júnior<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">---------------------------------------------------------------------------------<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:&nbsp;</span></strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">DISCOVER: Descobrindo a realidade do tratamento da diabetes tipo 2 no mundo real<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="color:#B22222;"><span style="font-size: 10.5pt; font-family: Helvetica, sans-serif;">Recrutamento completo</span></span><span style="font-size: 10.5pt; font-family: Helvetica, sans-serif;"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com DM tipo 2<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Renan Magalhães Montenegro Júnior<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif; color:#555555">---------------------------------------------------------------------------------<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Descrição:&nbsp;</span></strong><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Protocolo aberto, multicêntrico, de roll-over do pasireotida para os pacientes que concluíram pesquisa científica com o medicamento SOM230 patrocinado pela Novartis<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Status do estudo:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="color:#B22222;"><span style="font-size: 10.5pt; font-family: Helvetica, sans-serif;">Recrutamento completo</span></span><span style="font-size: 10.5pt; font-family: Helvetica, sans-serif;"><o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Perfil do participante de pesquisa:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">pacientes com acromegalia<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt 1.7pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Pesquisador Responsável:</span></strong><span class="apple-converted-space"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Renan Magalhães Montenegro Júnior<o:p></o:p></span></p> <p style="margin: 0cm 0cm 7.5pt; -webkit-tap-highlight-color: rgba(0, 0, 0, 0);"><strong style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0)"><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Contato para informação:</span></strong><span class="apple-converted-space"><b><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">&nbsp;</span></b></span><span style="font-size:10.5pt;font-family:&quot;Helvetica&quot;,sans-serif;color:#555555">Thisciane ou Stela (85) 3366-8590<o:p></o:p></span></p> </div> </div> </div> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse3">Gastroenterologia</a> </div> <div id="collapse3" class="accordion-body collapse"> <div class="accordion-inner"> <p><strong>Descrição:</strong> Estudo de fase III, randomizado, duplo-cego, controlado por placebo e multicêntrico para avaliar a eficácia (manutenção de remissão) e segurança do etrolizumabe comparado com placebo em pacientes com colite ulcerativa ativa, de moderada a grave, não tratados anteriormente com inibidores de TNF.</p> <p><strong>Status do estudo:</strong> <span style="color:#006400;">Recrutamento aberto</span></p> <p><strong>Perfil do participante de pesquisa: </strong>pacientes com colite ulcerativa ativa</p> <p><strong>Pesquisador Responsável:</strong> Lucia Libanez Bessa Campelo Braga</p> <p><strong>Contato para informação: </strong>Thisciane ou Stela (85) 3366-8590</p> <p><span style="font-family: Helvetica, sans-serif;">---------------------------------------------------------------------------------</span></p> <p><strong>Descrição:</strong>&nbsp;Estudo de extensão em regime aberto e de monitoramento da segurança de pacientes com colite ulcerativa moderada a grave anteriormente incluídos nos estudos de fase III do etrolizumabe.</p> <p><strong>Status do estudo:</strong> <span style="color:#006400;">Recrutamento aberto</span></p> <p><strong>Perfil do participante de pesquisa: </strong>pacientes com colite ulcerativa moderada a grave anteriormente incluídos nos estudos de fase III do etrolizumabe</p> <p><strong>Pesquisador Responsável:</strong> Lucia Libanez Bessa Campelo Braga</p> <p><strong>Contato para informação: </strong>Thisciane ou Stela (85) 3366-8590</p> </div> </div> </div> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse4">Ginecologia e Obstetrícia</a> </div> <div id="collapse4" class="accordion-body collapse"> <div class="accordion-inner"> <p><strong>Descrição:</strong> Utilização da metabolômica para identificação e validação de biomarcadores para parto pré-termo – SAMBA</p> <p><strong>Status do estudo:</strong> <span style="color:#006400;">Recrutamento aberto</span></p> <p><strong>Perfil do participante de pesquisa: </strong>mulheres grávidas do primeiro filho com xx semnas gestacionais</p> <p><strong>Pesquisador Responsável:</strong> Francisco Edson de Lucena Feitosa</p> <p><strong>Contato para informação: </strong>Thisciane ou Stela (85) 3366-859</p> </div> </div> </div> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse5">Hematologia</a> </div> <div id="collapse5" class="accordion-body collapse"> <div class="accordion-inner"> <p><strong>Descrição:&nbsp;</strong>Um Estudo Clínico de Fase 2, Randomizado, Controlado, Aberto, da Eficácia e Segurança de Pevonedistate Mais Azacitidina Versus Azacitidina como Agente Único em Pacientes com Síndromes Mielodisplásicas de Alto Risco, Leucemia Mielomonocítica Crônica e Leucemia Mieloide Aguda com Baixa Contagem de Blastos. Protocolo Pevonedistat-2001</p> <p><strong>Status do estudo:</strong>&nbsp;Aguardando o início do estudo.</p> <p><strong>Perfil do participante de pesquisa:&nbsp;</strong>pacientes com síndromes mielodisplásicas de alto risco, leucemia mielomonocítica crônica e leucemia mieloide aguda com baixa contagem de blasto</p> <p><strong>Pesquisador Responsável:</strong>&nbsp;Silvia Maria Meira Magalhães</p> <p><strong>Contato para informação:&nbsp;</strong>Thisciane ou Stela (85) 3366-8590</p> <p><span style="font-family: Helvetica, sans-serif;">---------------------------------------------------------------------------------</span></p> <p><strong>Descrição:</strong> Um estudo de fase III, randomizado, controlado, em caráter aberto, do VELCADE® (bortezomibe) Melfalano-Prednisona (VMP), comparado ao daratumumabe em combinação com VMP (D-VMP), em sujeitos com mieloma múltiplo previamente não tratados que não são elegíveis para terapia em dose elevada.</p> <p><strong>Status do estudo:</strong> <span style="color:#B22222;">Recrutamento completo</span></p> <p>Perfil do participante de pesquisa: pacientes com mieloma múltiplo previamente não tratados que não são elegíveis para terapia em dose elevada.</p> <p><strong>Pesquisador Responsável:</strong> Fernando Barroso Duarte</p> <p><strong>Contato para informação: </strong>Thisciane ou Stela (85) 3366-8590</p> </div> </div> </div> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse6">Infectologia</a> </div> <div id="collapse6" class="accordion-body collapse"> <div class="accordion-inner"> <p><strong>Descrição:</strong> Ensaio Clínico fase III duplo-cego randomizado controlado com placebo para a avaliação da eficácia e segurança da vacina Dengue 1, 2, 3, 4 (atenuada) do Instituto Butantan</p> <p><strong>Status do estudo:</strong> <span style="color:#006400;">Recrutamento aberto</span></p> <p><strong>Perfil do participante de pesquisa: </strong>pessoas entre 2 a 17 anos que queriam se vacinar contra a dengue.</p> <p><strong>Pesquisador Responsável:</strong> Ivo Castelo Branco Coelho</p> <strong>Contato para informação: </strong>Thisciane ou Stela (85) 33668590 </div> </div> </div> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse7">Neurologia</a> </div> <div id="collapse7" class="accordion-body collapse"> <div class="accordion-inner"> <p><strong>Descrição:</strong> Estudo da eficácia e segurança de 3 doses de S47445 versus placebo em participantes de pesquisa com doença de Alzheimer nos estágios leve a moderado com sintomas depressivos. Estudo de fase II, de 24 semanas, internacional, multicêntrico, randomizado, duplo-cego, controlado por placebo de monoterapia seguido por um período de extensão opcional de 28 semanas em coadministração com donepezila.</p> <p><strong>Status do estudo:</strong> <span style="color:#A52A2A;">Recrutamento encerrado</span></p> <p><strong>Perfil do participante de pesquisa:</strong> pessoas com doença de Alzheimer nos estágios leve a moderado com sintomas depressivos</p> <p><strong>Pesquisador Responsável:</strong> José Ibiapina Siqueira Neto</p> <p><strong>Contato para informação:</strong> Thisciane ou Stela (85) 3366-8590</p> </div> </div> </div> <div class="accordion-group"> <div class="accordion-heading"> <a class="accordion-toggle" data-toggle="collapse" data-parent="#accordion" href="#collapse8">Psiquiatria</a> </div> <div id="collapse8" class="accordion-body collapse"> <div class="accordion-inner"> <p><strong>Descrição:</strong> Estudo Randomizado, Duplo-Cego, Multicêntrico, com Controle Ativo para Avaliar a Eficácia, a Segurança e a Tolerabilidade de Doses Fixas de Escetamina Intranasal Mais um Antidepressivo Oral em Participantes da Pesquisa Adultos com Depressão Resistente a Tratamento” - TRANSFORM-1</p> <p><strong>Status do estudo:</strong> <span style="color:#006400;">Recrutamento aberto</span>
													</p> <p><strong>Perfil do participante de pesquisa:</strong> pessoas de 18 a 64 anos com depressão resistente a tratamento</p> <p><strong>Pesquisador Responsável:</strong> Fábio Gomes de Matos e Souza</p> <p><strong>Contato para informação: </strong>Thisciane ou Stela (85) 3366-8590</p> <p><span style="font-family: Helvetica, sans-serif;">---------------------------------------------------------------------------------</span></p> <p><strong>Descrição:</strong> Estudo Randomizado, Duplo-Cego, Multicêntrico, com Controle Ativo de Escetamina Intranasal Mais um Antidepressivo Oral para Prevenção de Recidiva na Depressão Resistente a Tratamento” - SUSTAIN-1</p> <p><strong>Status do estudo:</strong> <span style="color:#006400;">Recrutamento aberto</span></p> <p><strong>Perfil do participante de pesquisa:</strong> Pessoas de 18 a 64 anos com depressão resistente a tratamento</p> <p><strong>Pesquisador Responsável: </strong>Fábio Gomes de Matos e Souza</p> <p><strong>Contato para informação:</strong> Thisciane ou Stela (85) 3366-8590</p> <p><span style="font-family: Helvetica, sans-serif;">---------------------------------------------------------------------------------</span></p> <p><strong>Descrição:</strong> Estudo Aberto, de Longo Prazo, da Segurança e Eficácia da Escetamina Intranasal na Depressão Resistente a Tratamento” - SUSTAIN-2</p> <p><strong>Status do estudo:</strong> <span style="color:#006400;">Recrutamento aberto</span></p> <p><strong>Perfil do participante de pesquisa:</strong> homem ou mulher com ≥18 anos de idade com depressão resistente a tratamento</p> <p><strong>Pesquisador Responsável:</strong> Fábio Gomes de Matos e Souza</p> <p><strong>Contato para informação:</strong> Thisciane ou Stela (85) 33668590</p> </div> </div> </div> </div> </div> <br />
												</div> <div class="asset-metadata"> </div> </div> </div> </div>





					 			<div class="portlet-column portlet-column-last span4" id="_101_INSTANCE_jJ5D5VaFLatP_811263_columns-2">





													<div class="portlet-dropzone portlet-column-content portlet-column-content-last" id="layout-column__118_INSTANCE_UbigffJYZrBW__column-2"> <div class="portlet-boundary portlet-boundary_85_ portlet-static portlet-static-end portlet-site-map " id="p_p_id_85_INSTANCE_9nyeGdwgU4qN_" > <span id="p_85_INSTANCE_9nyeGdwgU4qN"></span> <section class="portlet" id="portlet_85_INSTANCE_9nyeGdwgU4qN"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Navegação')" > <img id="owel__118_INSTANCE_UbigffJYZrBW__column2_0" src="http://www.ebserh.gov.br/ebserh-internet-theme/images/spacer.png" alt="" style="background-image: url('http://www.ebserh.gov.br/sprite/html/icons/_sprite.png'); background-position: 50% -1056px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Navegação</span> </span> <span class="portlet-title-text">Navegação</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_85_INSTANCE_9nyeGdwgU4qN" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container" style=""> <div class="portlet-body"> <ul><li><a href="pesquisa.html" > Comitê de Ética em Pesquisa</a></li><li><a href="nucleo-de-apoio-ao-pesquisador.html" > Núcleo de Apoio ao Pesquisador</a></li><li><a href="unidade-de-pesquisa-clinica.html" > Unidade de Pesquisa Clínica</a></li><li><a href="nats.html" > NATS</a></li></ul> </div> </div> </div> </section> </div> </div>



					 		</div> </section> </div> </div> </div> </div> </div> </div>















							<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_" > <span id="p_1_WAR_kaleodesignerportlet"></span> </div> <form action="#" id="hrefFm" method="post" name="hrefFm"> <span></span> </form> <div id="back-to-the-top"> <a class="back-top" href="#back-top"><span class="b-top icon-chevron-up"></span>Voltar ao topo</a> </div> </div> </div> <footer id="footer" class="" role="contentinfo"> <div class="container"> <a id="irparaorodape"></a> <div class="row">

													<div id="footer-col-1" class="span3 portlet-column portlet-column-first footer-col"> <div class="footer-col-content"> <h3>Assuntos</h3> <div class="assuntos"> <div class="portlet-boundary portlet-boundary_85_ portlet-static portlet-static-end portlet-borderless portlet-site-map " id="p_p_id_85_INSTANCE_assuntos1_" > <span id="p_85_INSTANCE_assuntos1"></span> <div class="portlet-borderless-container" style=""> <div class="portlet-body"> <ul><li><a href="http://www.ebserh.gov.br/web/huwc-ufc/noticias" > Notícias</a></li><li><a href="ensino-e-pesquisa.html" > Ensino e Pesquisa</a></li><li><a href="ensino.html" > Ensino</a></li><li><a href="pesquisa.html" > Pesquisa</a></li><li><a href="sobre.html" > Sites Externos</a></li><li><a href="http://www.ebserh.gov.br/web/huwc-ufc" > Site - HUWC</a></li><li><a href="http://www.ebserh.gov.br/web/meac-ufc" > Site - MEAC</a></li></ul></li></ul> </div> </div> </div> </div> </div> </div>

													<div id="footer-col-2" class="span3 portlet-column footer-col"> <div class="footer-col-content"> <h3>Serviços</h3> </div> </div> <div id="footer-col-3" class="span3 portlet-column footer-col">
														<div class="footer-col-content"> <h3>Redes Sociais</h3> <a href="https://www.youtube.com/channel/UCsvsX24Q6g-kckH93PL1FGw" alt="YouTube" target="_blank">YouTube</a> <a href="https://www.flickr.com/photos/complexohospitalardaufc/albums/with/72157684893816272" alt="Flickr" target="_blank">Flickr</a> </div> </div> <div id="footer-col-4" class="span3 portlet-column portlet-column-last footer-col"> <div class="footer-col-content"> <h3>Navegação</h3> <a href="#" id="alto_contraste_id" class="contraste_off" title="Alto Contraste" accesskey="6">Alto Contraste</a> </div> </div> </div> </div> </footer> <div id="footer-bar"> <div class="container"> <!-- conteudo editavel no rodape --> <div id="footer-bar-container" class="container"> <div id="selo-acesso-informacao" style="display: inline-block; width: 22%; float: left; "> <a href="http://www.acessoainformacao.gov.br/" target="_blank"> <img alt="Acesso à Informação" src="http://www.ebserh.gov.br/documents/214604/214767/Selo+acesso+a+informação/834dfce9-d255-4b28-ae0e-8f7d66939d7e?t=1424805652499" /> </a> </div> <div id="texto-rodape" style="color: #ffffff; font-size: 12px; text-align: center; display: inline-block; width: 50%; margin: 0 auto;"> Rua Capitão Francisco Pedro nº 1290, Bairro: Rodolfo Teófilo </br> Fortaleza - CE </br> CEP: 60430-370 </div> <div id="selo-governo" style="display: inline-block; width: 22%; float: right;"> </div> </div> </div> </div> </div> <script src="../../notifications-portlet/notifications/js/maincbcb.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652236000" type="text/javascript"></script> <script src="../../acesso-hospitais-portlet/js/main8e96.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1519652255000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_85_INSTANCE_assuntos1_",portletId:"85_INSTANCE_assuntos1",refreshURL:"\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d804576\x26p_p_id\x3d85_INSTANCE_assuntos1\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fhuwc-ufc\x252Fpesquisa"});Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7_",portletId:"ebserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7",refreshURL:"\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d804576\x26p_p_id\x3debserhbuscaavancada_WAR_ebserhbuscaavancadaportlet_INSTANCE_E3j7\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fhuwc-ufc\x252Fpesquisa"});Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_acessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7_",portletId:"acessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7",refreshURL:"\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d804576\x26p_p_id\x3dacessohospitais_WAR_acessohospitaisportlet_INSTANCE_E3j7\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fhuwc-ufc\x252Fpesquisa"});Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_71_INSTANCE_dm2zxVz2POIF_",portletId:"71_INSTANCE_dm2zxVz2POIF",refreshURL:"\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d804576\x26p_p_id\x3d71_INSTANCE_dm2zxVz2POIF\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fhuwc-ufc\x252Fpesquisa"});Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_101_INSTANCE_jJ5D5VaFLatP_",portletId:"101_INSTANCE_jJ5D5VaFLatP",refreshURL:"\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d804576\x26p_p_id\x3d101_INSTANCE_jJ5D5VaFLatP\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-2\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fhuwc-ufc\x252Fpesquisa"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("pesquisacf92.html?p_p_id=2_WAR_kaleodesignerportlet&amp;p_p_lifecycle=0");e.setParameter("mvcPath","http://www.ebserh.gov.br/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("uiScope",c.uiScope);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d804576\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fhuwc-ufc\x252Fpesquisa"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:30,redirectOnExpire:false,redirectUrl:"http\x3a\x2f\x2fwww\x2eebserh\x2egov\x2ebr\x2fweb\x2fportal-ebserh\x2finicio",warningLength:1})})()});</script> <script src="../../ebserh-internet-theme/js/main66e4.js?browserId=other&amp;minifierType=js&amp;languageId=pt_BR&amp;b=6210&amp;t=1473776398000" type="text/javascript"></script> <script type="text/javascript"></script> <script defer="defer" async="async" src="../../../barra.brasil.gov.br/barra.js" type="text/javascript"></script> </body>
<!-- Mirrored from www.ebserh.gov.br/web/huwc-ufc/pesquisa by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 05 Mar 2018 05:20:28 GMT -->
</html>
